Drug maker AbbVie reports 'excellent' third quarter
Thanks to increased sales of its Humira, Skyrizi and Rinvoq immunology drugs, AbbVie Inc. reported a big increase in its third-quarter sales and earnings.
The North Chicago-based drug maker (Nasdaq: ABBV) reported third-quarter net revenue rose 11.2% to $14.342 billion, and adjusted diluted earnings per share rose 17.7% to $3.33, which were both above analysts' expectations. Analysts polled by Thomson Reuters First Call expected third-quarter revenu e of $14.3 billion and earnings of $3.22 per share.
""We…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ben Miller Source Type: news